Overview
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
News
Nikon Z-Suite – the extraordinary power of contrast!
Student visit at JZO – an inspiring meeting in our laboratory
We are winners of Forbes Diamonds 2025!
Dinner with Marzena Rogalska – event report as part of the “Polska w okularach” campaign
A wonderful meeting with Marzena Rogalska at Centrum Optyczne Calisia in Kalisz!
Industry
Bank accounts
Registered as a VAT taxpayer on 2002-08-01. Active
56 1030 1289 0000 0000 8646 6023- 78 1030 1289 0000 0000 8646 6015
- 89 1030 1289 0000 0000 8646 6011
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 26, 2018 | Transformation registered |
Public aid
5 public aid cases recorded, with a total value of $19,506.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $3,987$3,987 | Tauron Sprzedaż sp. z o.o. | |
| Apr 23, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $4,822$4,822 | Starosta Karkonoski | |
| May 9, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,907$2,907 | Starosta Karkonoski |
Tenders
No recorded participation in tenders.
Trademarks
JZO holds 17 active trademarks registered with the Polish Patent Office. 1 application is pending. 1 mark has expired or was not registered. The first mark was filed in 2009.
| Mark | Protected until | |
|---|---|---|
| JZO EyeView PRO(word) | Feb 9, 2036 | |
| ClearStart UV(word) | Jul 11, 2035 | |
| RESIST MAX UV(word) | Jun 17, 2035 | |
| SOLVEO(word) | May 26, 2035 | |
| SUPREO(word) | Oct 20, 2033 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Waste generation | Active |
Authorized Representatives
Manner of representation
The following persons are authorised to make declarations of will on behalf of the company: 1. In the event of a multi-member management board – the President of the Management Board independently or two members of the management board other than the President of the Management Board acting jointly; 1. In the event of a one-person management board – a member of the management board independently.
Supervisory board
Ownership
| Owner | Share value | Stake |
|---|---|---|
Invoptic S.a.s. | $278,363.05 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| InmedS.A. | $13,860,648.96 | inmed.pl | ||
| Zakład Optyczny Oculussp. z o.o. | $332,546.80 | oculus.com.pl | ||
| Platinumsp. z o.o. | $313,097.87 | platinum-klinika.pl | ||
| Markdentsp. z o.o. | $129,752.97 | mark-dent.pl | ||
| K&J Polskasp. z o.o. | $70,953.51 | kjpolska.pl | ||
| Hemolens Diagnosticssp. z o.o. | $37,964.68 | hemolens.com | ||
| Pragma System Globalsp. z o.o. | $34,880.66 | pragma.systems | ||
| Selex Polskasp. z o.o. | $7,765.44 | selexpolska.com | ||
| Hetaloxsp. z o.o. | $965.71 | hetalox.com | ||
| Spinetime Solutionssp. z o.o. | – | spinetime.eu |
FAQ
Last updated: 2026-04-20